These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 11334421

  • 1. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND, Thalén PG, Jacinto SM, Ljung B.
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [Abstract] [Full Text] [Related]

  • 2. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
    Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW.
    Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
    [Abstract] [Full Text] [Related]

  • 3. Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice.
    Muurling M, Mensink RP, Pijl H, Romijn JA, Havekes LM, Voshol PJ.
    Metabolism; 2003 Aug; 52(8):1078-83. PubMed ID: 12898477
    [Abstract] [Full Text] [Related]

  • 4. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM.
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [Abstract] [Full Text] [Related]

  • 5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [Abstract] [Full Text] [Related]

  • 6. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
    Ye JM, Frangioudakis G, Iglesias MA, Furler SM, Ellis B, Dzamko N, Cooney GJ, Kraegen EW.
    Endocrinology; 2002 Dec; 143(12):4527-35. PubMed ID: 12446579
    [Abstract] [Full Text] [Related]

  • 7. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ, Kushwaha RS, DeFronzo RA.
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [Abstract] [Full Text] [Related]

  • 8. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.
    Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW.
    Metabolism; 1997 Aug; 46(8):935-42. PubMed ID: 9258278
    [Abstract] [Full Text] [Related]

  • 9. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
    Kalderon B, Mayorek N, Ben-Yaacov L, Bar-Tana J.
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
    Miyazaki Y, He H, Mandarino LJ, DeFronzo RA.
    Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
    [Abstract] [Full Text] [Related]

  • 11. The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.
    Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F.
    Diabetologia; 2005 Jan; 48(1):83-95. PubMed ID: 15619071
    [Abstract] [Full Text] [Related]

  • 12. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K, Tobe K, Ide T, Mochizuki T, Ohashi M, Akanuma Y, Yazaki Y, Kadowaki T.
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [Abstract] [Full Text] [Related]

  • 13. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK, Wi JK, Youn JH.
    Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between adipose phosphoenolpyruvate carboxykinase and occurrence and reversion of insulin resistance].
    Zhao WH, Xiao JZ, Yang WY, Wang N, Wang X, Chen XP, Bu S.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3074-8. PubMed ID: 16324411
    [Abstract] [Full Text] [Related]

  • 15. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.
    Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF.
    Diabetes; 2002 Mar 16; 51(3):797-802. PubMed ID: 11872682
    [Abstract] [Full Text] [Related]

  • 16. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.
    de Souza CJ, Hirshman MF, Horton ES.
    Diabetes; 1997 Aug 16; 46(8):1257-63. PubMed ID: 9231648
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.
    Kim JK, Fillmore JJ, Gavrilova O, Chao L, Higashimori T, Choi H, Kim HJ, Yu C, Chen Y, Qu X, Haluzik M, Reitman ML, Shulman GI.
    Diabetes; 2003 Jun 16; 52(6):1311-8. PubMed ID: 12765938
    [Abstract] [Full Text] [Related]

  • 18. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat.
    Laplante M, Festuccia WT, Soucy G, Blanchard PG, Renaud A, Berger JP, Olivecrona G, Deshaies Y.
    Am J Physiol Regul Integr Comp Physiol; 2009 Jan 16; 296(1):R57-66. PubMed ID: 18971352
    [Abstract] [Full Text] [Related]

  • 19. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.
    Diabetes; 1996 May 16; 45(5):659-66. PubMed ID: 8621019
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
    Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ.
    Mol Pharmacol; 2001 Apr 16; 59(4):765-73. PubMed ID: 11259621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.